Home Stock

Stock Research: Cosmo Pharmaceuticals

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Cosmo Pharmaceuticals

SWX:COPN NL0011832936
75
  • Value
    30
  • Growth
    63
  • Safety
    Safety
    90
  • Combined
    77
  • Sentiment
    64
  • 360° View
    360° View
    75
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Cosmo Pharmaceuticals N.V. is a pharmaceutical company focused on gastrointestinal diseases, dermatology, and healthtech. It operates in the pharmaceutical industry and its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, GI Genius, Eleview, Aemcolo, Methylene Blue MMX, and Winlevi. In the last fiscal year, the company had a market cap of $1,357 million, profits of $229 million, and revenue of $276 million, with 322 employees.

more
Strongest Rank Price vs. Sales (P/S)
Weakest Rank Liquidity
Country Luxembourg
Industry Pharmaceuticals
Size Small
Website cosmopharma.com
Index
SPI
Cosmo Pharmaceuticals stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 34 57 32
Growth
63 45 77 33
Safety
Safety
90 54 30 47
Sentiment
64 94 100 74
360° View
360° View
75 67 94 36
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
97 87 100 95
Opinions Change
16 50 83 50
Pro Holdings
n/a 96 80 60
Market Pulse
73 57 53 21
Sentiment
64 94 100 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 34 57 32
Growth
63 45 77 33
Safety Safety
90 54 30 47
Combined
77 43 62 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
10 75 46 5
Price vs. Earnings (P/E)
7 13 18 7
Price vs. Book (P/B)
40 59 67 85
Dividend Yield
67 1 70 57
Value
30 34 57 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
85 8 88 8
Profit Growth
8 100 98 100
Capital Growth
49 33 15 44
Stock Returns
89 45 38 22
Growth
63 45 77 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
94 95 46 39
Refinancing
33 43 39 78
Liquidity
100 24 29 19
Safety Safety
90 54 30 47

Similar Stocks

Discover high‑ranked alternatives to Cosmo Pharmaceuticals and broaden your portfolio horizons.

BMW

XTRA:BMW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Repsol

BME:REP
Country: Spain
Industry: Oil & Gas Integrated
Size: X-Large
Full Stock Analysis

Ternium

NYSE:TX
Country: Luxembourg
Industry: Steel
Size: Large
Full Stock Analysis

Krka

LJSE:KRKG
Country: Slovenia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews